Pain-Topics.org Addresses Oxycodone Safety Concerns
Contrary to negative reports in the mass media, with proper prescribing, appropriate risk management, and effective patient education, oxycodone is a useful and relatively safe opioid for pain management.
Chicago, IL, June 12, 2007 --(PR.com)-- Although oxycodone is an older opioid analgesic, used for more than 80 years, it has been in the news lately for all the wrong reasons -- with sensational stories telling of its misuse, abuse, and overdose. Concerns about oxycodone have been justified; however, with proper prescribing, appropriate risk management, and effective patient education, it remains a useful and relatively safe analgesic option for pain management.
A new, peer-reviewed report exclusively from Pain Treatment Topics provides guidance on the safe prescribing of immediate release (IR) and controlled release (CR) oxycodone. Additionally, a patient instructions handout emphasizes medication compliance and safety to help prevent accidental misuse and avoidable adverse events.
To access these free documents, go to:
http://www.pain-topics.org/opioid_rx/oxycodone.php#OxyRx
***Commonsense Oxycodone Prescribing & Safety***
This guidance paper discusses the safe prescribing of all oxycodone formulations. Generally, oxycodone is reserved for patients having intolerable adverse effects from morphine or other opioids that prevent adequate titration for desired analgesia. Its ultimate role depends on patient response, prescriber comfort in using the agent, and relative cost considerations
***Patient Instructions Handout: Safely Taking Oxycodone***
To assist healthcare providers in their vital patient-education responsibilities, special 2-page, “Patient Instructions” handouts on the safe use of oxycodone are available in English and Spanish. These can be downloaded and reproduced free of charge for distribution at the time oxycodone analgesia is prescribed. Of special importance, each handout describes warning signs of oxycodone overdose, and instructs family members or caregivers to immediately seek emergency assistance if any occur.
###
Pain Treatment Topics and the Pain-Topics.org website provide open and free access to noncommercial, evidence-based clinical news, information, research, and education on the causes and effective treatment of the many types of pain conditions. It is independently produced and currently supported by an unrestricted educational grant from Mallinckrodt Inc., St. Louis, MO, a leading manufacturer of generic opioid analgesic products.
A new, peer-reviewed report exclusively from Pain Treatment Topics provides guidance on the safe prescribing of immediate release (IR) and controlled release (CR) oxycodone. Additionally, a patient instructions handout emphasizes medication compliance and safety to help prevent accidental misuse and avoidable adverse events.
To access these free documents, go to:
http://www.pain-topics.org/opioid_rx/oxycodone.php#OxyRx
***Commonsense Oxycodone Prescribing & Safety***
This guidance paper discusses the safe prescribing of all oxycodone formulations. Generally, oxycodone is reserved for patients having intolerable adverse effects from morphine or other opioids that prevent adequate titration for desired analgesia. Its ultimate role depends on patient response, prescriber comfort in using the agent, and relative cost considerations
***Patient Instructions Handout: Safely Taking Oxycodone***
To assist healthcare providers in their vital patient-education responsibilities, special 2-page, “Patient Instructions” handouts on the safe use of oxycodone are available in English and Spanish. These can be downloaded and reproduced free of charge for distribution at the time oxycodone analgesia is prescribed. Of special importance, each handout describes warning signs of oxycodone overdose, and instructs family members or caregivers to immediately seek emergency assistance if any occur.
###
Pain Treatment Topics and the Pain-Topics.org website provide open and free access to noncommercial, evidence-based clinical news, information, research, and education on the causes and effective treatment of the many types of pain conditions. It is independently produced and currently supported by an unrestricted educational grant from Mallinckrodt Inc., St. Louis, MO, a leading manufacturer of generic opioid analgesic products.
Contact
Pain Treatment Topics
Stewart B. Leavitt, MA, PhD
847-724-3091
www.pain-topics.org
Stewart B. Leavitt, MA, PhD
847-724-3091
www.pain-topics.org
Contact
Categories